Latest Epstein–Barr virus infection Stories
There is “an increased frequency of latent EBV-infected B cells in MS,” according to a study published in Acta Neurologica Scandinavica on March 31, 2014 (1).
Large families and smoking have an independent impact on EBV infection that is not accounted for by other sociodemographic factors, according to a new study published in PLoS One in May, 2013.
More than 90 percent of humans have antibodies to the Epstein Barr virus.
A new study from researchers at Queen Mary, University of London shows how a particular virus tricks the immune system into triggering inflammation and nerve cell damage in the brain, which is known to cause MS.
Epstein-Barr virus (EBV) infects nine out of ten people worldwide at some point during their lifetimes.
At present, while there is no cause known for this condition, patients with MS seem to have genetic vulnerability to certain environmental factors that could trigger this condition, such as the Epstein-Barr virus.
Epstein-Barr virus (EBV) infects 90% of people at some point in their lives - and most will never know it.
About 90 percent of people are infected at some time in their lives with Epstein-Barr virus (EBV), usually with no ill effects.
A new discovery by UNC scientists describes how cells infected by the Epstein-Barr virus (EBV) produce small vesicles or sacs called exosomes, changing their cellular "cargo" of proteins and RNA.
SEATTLE, Aug. 11 /PRNewswire/ -- HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection.
The Epstein-Barr virus (EBV), or human herpesvirus 4, is part of the herpes family and causes cancer. It is one of the most common viruses in humans and is correlated to the pathogenesis of multiple autoimmune diseases including rheumatoid arthritis, systemic lupus, dermatomyositis, and multiple sclerosis. It can also cause several lymphoproliferative disorders and cancers. Most people gain adaptive immunity after being infected by EBV. In the US half of all five-year-olds and 90-95% of...